Insights into length-dependent regulation of cardiac cross-bridge cycling kinetics in human myocardium

Arch Biochem Biophys. 2016 Jul 1:601:48-55. doi: 10.1016/j.abb.2016.02.005. Epub 2016 Feb 18.

Abstract

Cross-bridge cycling kinetics play an essential role in the heart's ability to contract and relax. The rate of tension redevelopment (ktr) slows down as a muscle length is increased in intact human myocardium. We set out to determine the effect of rapid length step changes and protein kinase A (PKA) and protein kinase C-βII (PKC-βII) inhibitors on the ktr in ultra-thin non-failing and failing human right ventricular trabeculae. After stabilizing the muscle either at L90 (90% of optimal length) or at Lopt (optimal length), we rapidly changed the length to either Lopt or L90 and measured ktr. We report that length-dependent changes in ktr occur very rapidly (in the order of seconds or faster) in both non-failing and failing muscles and that the length at which a muscle had been stabilized prior to the length change does not significantly affect ktr. In addition, at L90 and at Lopt, PKA and PKC-βII inhibitors did not significantly change ktr. Our results reveal that length-dependent regulation of cross-bridge cycling kinetics predominantly occurs rapidly and involves the intrinsic properties of the myofilament rather than post-translational modifications that are known to occur in the cardiac muscle as a result of a change in muscle/sarcomere length.

Keywords: Cross-bridge cycling kinetics; Muscle length; Post-translational modification; Rate of tension redevelopment; Trabeculae.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Female
  • Heart / physiology*
  • Heart Failure / metabolism
  • Heart Ventricles / metabolism
  • Humans
  • Isoquinolines / chemistry
  • Kinetics
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Myocardium / metabolism*
  • Myofibrils / physiology*
  • Protein Kinase C beta / antagonists & inhibitors
  • Sarcomeres / physiology*
  • Signal Transduction
  • Sulfonamides / chemistry

Substances

  • Isoquinolines
  • Sulfonamides
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C beta
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide